We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrasound Tools Provides Confidence in Cardiac Care

By HospiMedica International staff writers
Posted on 20 Sep 2015
A new anatomically intelligent ultrasound (AIUS) tool brings advanced quantification, automated 3-D views, and robust reproducibility to echocardiology. More...


The Royal Philips (Amsterdam, The Netherlands) HeartModelA.I is designed to automatically detect, segment, and quantify the left atrium (LA) and left ventricle (LV) volume and ejection fraction (EF). The model-based segmentation algorithm is based on prior knowledge of the general structural layout of the heart, how heart location varies within an image, the ways in which the heart shape varies, and the ways in which the heart is imaged using ultrasound. This prior information is what enables the HeartModelA.I. to adapt the model to hearts typically seen in a clinical scenario.

Clinically, HeartModelA.I is designed to detect two LV endocardial borders, at end-diastole (ED) and end-systole (ES). The two endocardial borders mark the inner and outer extents of the myocardial tissue at the blood-tissue interface and at the interface of the compacted myocardium. By thus segmenting the inner and outer extents of the myocardial tissue, an intermediate location can be more robustly defined across a wide range of heart shapes and image quality 3-6 times faster than current methods that are based on using 3D measurements.

When editing of the borders is necessary, the user has two editing options available - a global or regional edit. The global edit consists of adjusting the ED or ES slider value, or relative location of the single LV endocardial border relative to the inner and outer borders that were automatically detected by the algorithm. Regional editing involves adjusting the border on a more localized basis via control points placed along the contour, allows the user to use the application even on hearts exhibiting a very unique or irregular shape.

“Health systems are constantly looking for solutions to provide the most efficient and effective way to help clinicians make confident diagnosis,” said Vitor Rocha, CEO of ultrasound at Philips. “Conventional echocardiograms can be very time consuming. By combining AIUS with the power of HeartModelA.I, we’re able to deliver technology that helps simplify a complicated exam and makes it more reproducible.”

Ultrasound provides a cost-effective, robust imaging modality to measure cardiac function without radiation exposure. Typically, two dimensional (2D) echocardiographic images are used to measure LA or LV volume and EF output, but these measurements rely on making assumptions about the 3-D shape of the heart based only on what is seen in the 2-D image, an assumption that can significantly impact the measurements.

Related Links:

Royal Philips



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Desk Aneroid Sphyg
Diagnostix 750D+
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.